Adel M. Moussa

Person

Burlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Crystalline epinephrine malonate salt
- Patent number 12,134,588
- Issue date Nov 5, 2024
- Biothea Pharma, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substitut...
- Patent number 12,084,473
- Issue date Sep 10, 2024
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
- Patent number 12,006,340
- Issue date Jun 11, 2024
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2′-substituted-N6-substituted purine nucleotides for RNA virus trea...
- Patent number 11,975,016
- Issue date May 7, 2024
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly active compounds against COVID-19
- Patent number 11,813,278
- Issue date Nov 14, 2023
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly active compounds against COVID-19
- Patent number 11,738,038
- Issue date Aug 29, 2023
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly active compounds against COVID-19
- Patent number 11,707,480
- Issue date Jul 25, 2023
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of HCV infected patients with cirrhosis
- Patent number 11,690,860
- Issue date Jul 4, 2023
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline epinephrine malonate salt
- Patent number 11,505,521
- Issue date Nov 22, 2022
- Biothea Pharma, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline epinephrine malonate salt
- Patent number 10,995,059
- Issue date May 4, 2021
- Biothea Pharma, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2′-substituted-N6-substituted purine nucleotides for RNA virus trea...
- Patent number 10,946,033
- Issue date Mar 16, 2021
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
- Patent number 10,906,928
- Issue date Feb 2, 2021
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
- Patent number 10,894,804
- Issue date Jan 19, 2021
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substitut...
- Patent number 10,875,885
- Issue date Dec 29, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Highly active compounds against COVID-19
- Patent number 10,874,687
- Issue date Dec 29, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substitut...
- Patent number 10,870,672
- Issue date Dec 22, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substitut...
- Patent number 10,870,673
- Issue date Dec 22, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substitut...
- Patent number 10,815,266
- Issue date Oct 27, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2′,4′-bridged nucleosides for HCV infection
- Patent number 10,723,754
- Issue date Jul 28, 2020
- Idenix Pharmaceuticals LLC
- Benjamin Alexander Mayes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
D-amino acid compounds for liver disease
- Patent number 10,717,758
- Issue date Jul 21, 2020
- Idenix Pharmaceuticals LLC
- Benjamin Alexander Mayes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-s...
- Patent number 10,711,029
- Issue date Jul 14, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4′-or nucleosides for the treatment of HCV
- Patent number 10,683,321
- Issue date Jun 16, 2020
- Idenix Pharmaceuticals LLC
- David Dukhan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
- Patent number 10,519,186
- Issue date Dec 31, 2019
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2′-chloro nucleoside analogs for HCV infection
- Patent number 10,513,534
- Issue date Dec 24, 2019
- Idenix Pharmaceuticals LLC
- Gilles Gosselin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for making nucleoside phosphoramidate compounds
- Patent number 10,251,903
- Issue date Apr 9, 2019
- Merck Sharp & Dohme Corp.
- Bryon L. Simmons
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine...
- Patent number 10,238,680
- Issue date Mar 26, 2019
- Idenix Pharmaceuticals LLC
- Benjamin Alexander Mayes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6...
- Patent number 10,239,911
- Issue date Mar 26, 2019
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and am...
- Patent number 10,231,986
- Issue date Mar 19, 2019
- Idenix Pharmaceuticals LLC
- David Dukhan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substit...
- Patent number 10,202,412
- Issue date Feb 12, 2019
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substitute...
- Patent number 10,005,811
- Issue date Jun 26, 2018
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19
- Publication number 20240261316
- Publication date Aug 8, 2024
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19
- Publication number 20240238324
- Publication date Jul 18, 2024
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2'-CHLORO-2'-FLUORO-N2-AMINO-N6-METHYLAMINO PURINE NUCLEOTIDES FOR...
- Publication number 20240226131
- Publication date Jul 11, 2024
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADVANTAGEOUS ANTI-HCV COMBINATION THERAPY
- Publication number 20240148770
- Publication date May 9, 2024
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS
- Publication number 20240018179
- Publication date Jan 18, 2024
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6...
- Publication number 20240002426
- Publication date Jan 4, 2024
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADVANTAGEOUS MORPHIC FORM OF AT-527 HEMI-SULFATE SALT
- Publication number 20230365611
- Publication date Nov 16, 2023
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NIRAN INTERFERING DRUGS FOR SARS-COV-2 MUTANT THERAPY
- Publication number 20230364121
- Publication date Nov 16, 2023
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES
- Publication number 20230331751
- Publication date Oct 19, 2023
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE EPINEPHRINE MALONATE SALT
- Publication number 20230086578
- Publication date Mar 23, 2023
- Biothea Pharma, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES
- Publication number 20230049294
- Publication date Feb 16, 2023
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREA...
- Publication number 20230017958
- Publication date Jan 19, 2023
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19
- Publication number 20220347200
- Publication date Nov 3, 2022
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19
- Publication number 20220347199
- Publication date Nov 3, 2022
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6...
- Publication number 20220267366
- Publication date Aug 25, 2022
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS
- Publication number 20210277045
- Publication date Sep 9, 2021
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19
- Publication number 20210275563
- Publication date Sep 9, 2021
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE EPINEPHRINE MALONATE SALT
- Publication number 20210214301
- Publication date Jul 15, 2021
- Biothea Pharma, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS
- Publication number 20210087217
- Publication date Mar 25, 2021
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF HCV INFECTED PATIENTS WITH CIRRHOSIS
- Publication number 20210015841
- Publication date Jan 21, 2021
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6...
- Publication number 20210009628
- Publication date Jan 14, 2021
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6...
- Publication number 20200331955
- Publication date Oct 22, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6...
- Publication number 20200331956
- Publication date Oct 22, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS
- Publication number 20200331954
- Publication date Oct 22, 2020
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6...
- Publication number 20200308215
- Publication date Oct 1, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREA...
- Publication number 20200222442
- Publication date Jul 16, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY ACTIVE DRUG COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS
- Publication number 20200179415
- Publication date Jun 11, 2020
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS
- Publication number 20200087339
- Publication date Mar 19, 2020
- Atea Pharmaceuticals, Inc.
- Adel Moussa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE EPINEPHRINE MALONATE SALT
- Publication number 20200031758
- Publication date Jan 30, 2020
- Biothea Pharma, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREA...
- Publication number 20190201433
- Publication date Jul 4, 2019
- Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Adel M. Moussa

Person

Patents Grantslast 30 patents

Crystalline epinephrine malonate salt

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substitut...

Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

2′-substituted-N6-substituted purine nucleotides for RNA virus trea...

Highly active compounds against COVID-19

Highly active compounds against COVID-19

Highly active compounds against COVID-19

Treatment of HCV infected patients with cirrhosis

Crystalline epinephrine malonate salt

Crystalline epinephrine malonate salt

2′-substituted-N6-substituted purine nucleotides for RNA virus trea...

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substitut...

Highly active compounds against COVID-19

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substitut...

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substitut...

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substitut...

2′,4′-bridged nucleosides for HCV infection

D-amino acid compounds for liver disease

Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-s...

4′-or nucleosides for the treatment of HCV

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

2′-chloro nucleoside analogs for HCV infection

Process for making nucleoside phosphoramidate compounds

D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine...

Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6...

Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and am...

β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substit...

β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substitute...

Patents Applicationslast 30 patents

HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19

HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19

2'-CHLORO-2'-FLUORO-N2-AMINO-N6-METHYLAMINO PURINE NUCLEOTIDES FOR...

ADVANTAGEOUS ANTI-HCV COMBINATION THERAPY

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6...

ADVANTAGEOUS MORPHIC FORM OF AT-527 HEMI-SULFATE SALT

NIRAN INTERFERING DRUGS FOR SARS-COV-2 MUTANT THERAPY

STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES

CRYSTALLINE EPINEPHRINE MALONATE SALT

STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES

2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREA...

HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19

HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19

BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6...

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19

CRYSTALLINE EPINEPHRINE MALONATE SALT

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

TREATMENT OF HCV INFECTED PATIENTS WITH CIRRHOSIS

Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6...

BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6...

BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6...

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6...

2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREA...

HIGHLY ACTIVE DRUG COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

CRYSTALLINE EPINEPHRINE MALONATE SALT

2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREA...